Device Trial Radar · NCT03570034
Obalon Balloon System Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Apr 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
201
Actual
Start
Jun 15, 2018
Primary completion
Sep 13, 2020
Study completion Mar 13, 2021
Sponsor
- Lead sponsor
- Obalon Therapeutics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 26, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The Obalon Balloon System - Post-Approval Study is a prospective, observational, and multi-center study.
Conditions
- Obesity
Interventions
Obalon Balloon SystemDevice
Obalon Balloon System with a moderate intensity Weight Loss Behavioral Modification Program
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serious Adverse EventTime frame: 6-Month
- Percentage of Patients with at least 5% TBWLTime frame: 6-Month
- Mean % TBWLTime frame: 6-Month
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Smart Dimensions Weight Loss
Fountain Valley, California
Davtyan Medical Weight Loss and Wellness
Glendale, California
Lifetime Surgical Weight Loss
Los Gatos, California
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.